Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis

Concepts

• therapeutic apheresis services
• bristol
• medical consumables
• nhsbt
• nhsbt low density lipid
• removal apheresis
• maintenance of the existing art
• ldl
• removal
• clinical services directorate of nhsbt

Location

United Kingdom:

Description

The award is for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887. Please see section II.2.4 for detailed description of the procurement.

Total Quantity or Scope

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection. The requirement for this procurement was for the supply of consumables and maintenance of the existing ART Universal machines. … As a result of the tender, a Framework Agreement for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis for a period of 2 years with two 1-year options to extend has been awarded to Fresenius Medical Care (UK) Ltd.

Award Detail

Award Criteria

CPV Codes

• 33140000 - Medical consumables
• 33693000 - Other therapeutic products
• 50421000 - Repair and maintenance services of medical equipment

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **